Chitinases and chitinase-like proteins as therapeutic targets in inflammatory diseases, with a special focus on inflammatory bowel diseases
M Mazur, A Zielińska, MM Grzybowski, J Olczak… - International Journal of …, 2021 - mdpi.com
Chitinases belong to the evolutionarily conserved glycosyl hydrolase family 18 (GH18). They
catalyze degradation of chitin to N-acetylglucosamine by hydrolysis of the β-(1-4)-glycosidic …
catalyze degradation of chitin to N-acetylglucosamine by hydrolysis of the β-(1-4)-glycosidic …
[HTML][HTML] Lactobacillus plantarum CCFM8610 alleviates irritable bowel syndrome and prevents gut microbiota dysbiosis: A randomized, double-blind, placebo …
Irritable bowel syndrome with diarrhea (IBS-D) is chronic intestinal dysfunction with diarrhea
and other complicated clinical symptoms, and it has a great impact on the daily life and …
and other complicated clinical symptoms, and it has a great impact on the daily life and …
Intestinal neuropod cell GUCY2C regulates visceral pain
JR Barton, AK Londregan… - The Journal of …, 2023 - Am Soc Clin Investig
Visceral pain (VP) is a global problem with complex etiologies and limited therapeutic
options. Guanylyl cyclase C (GUCY2C), an intestinal receptor producing cyclic GMP (cGMP) …
options. Guanylyl cyclase C (GUCY2C), an intestinal receptor producing cyclic GMP (cGMP) …
Altered gut microbiota–host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern
Background Dysregulation of gut microbiota–host bile acid (BA) co-metabolism is a critical
pathogenic factor of diarrhea-predominant irritable bowel syndrome (IBS-D). Traditional …
pathogenic factor of diarrhea-predominant irritable bowel syndrome (IBS-D). Traditional …
Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome
K Niewinna, A Zielińska, J Fichna - Expert Opinion on …, 2020 - Taylor & Francis
Introduction: Irritable bowel syndrome (IBS) is a complex functional gut disorder that typically
manifests in early adult years. More than a third of IBS patients are diagnosed with …
manifests in early adult years. More than a third of IBS patients are diagnosed with …
Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome
The human nociceptor-specific voltage-gated sodium channel 1.7 (hNaV1. 7) is critical for
sensing various types of somatic pain, but it appears not to play a primary role in acute …
sensing various types of somatic pain, but it appears not to play a primary role in acute …
Long‐lasting visceral hypersensitivity in a model of DSS‐induced colitis in rats
S López‐Estévez… - …, 2022 - Wiley Online Library
Background Persistent visceral hypersensitivity is a key component of functional and
inflammatory gastrointestinal diseases. Current animal models fail to fully reproduce the …
inflammatory gastrointestinal diseases. Current animal models fail to fully reproduce the …
Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study
K Van Malderen, N Hanning, H Lambrechts… - Frontiers in …, 2022 - frontiersin.org
Background Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder for which
no diagnostic tools are currently available. Patients are diagnosed using the Rome IV …
no diagnostic tools are currently available. Patients are diagnosed using the Rome IV …
Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS
KJ Kamp, KR Weaver, LAB Sherwin, P Barney… - Journal of …, 2019 - Elsevier
Objective Adults with irritable bowel syndrome (IBS) often report extraintestinal pain, fatigue,
and sleep disturbances in addition to abdominal pain. Few interventions have sought to …
and sleep disturbances in addition to abdominal pain. Few interventions have sought to …
Innovative cognitive behavioral therapies for irritable bowel syndrome: processes, predictors, platforms, and outcomes
JM Lackner - Pain, 2024 - journals.lww.com
With a global estimated prevalence of 15%, 74 irritable bowel syndrome (IBS) is both the
most common visceral pain disorder and gastrointestinal disorder. 34 Symptoms include …
most common visceral pain disorder and gastrointestinal disorder. 34 Symptoms include …